Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

CollPlant Biotechnologies (CLGN) Assets Average (2018 - 2025)

Historic Assets Average for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to $15.8 million.

  • CollPlant Biotechnologies' Assets Average rose 1857.03% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 1857.03%. This contributed to the annual value of $26.4 million for FY2024, which is 2650.85% down from last year.
  • As of Q3 2025, CollPlant Biotechnologies' Assets Average stood at $15.8 million, which was up 1857.03% from $8.7 million recorded in Q2 2025.
  • In the past 5 years, CollPlant Biotechnologies' Assets Average registered a high of $54.3 million during Q3 2021, and its lowest value of $5.4 million during Q1 2021.
  • Its 5-year average for Assets Average is $27.3 million, with a median of $20.8 million in 2023.
  • As far as peak fluctuations go, CollPlant Biotechnologies' Assets Average skyrocketed by 81714.4% in 2022, and later crashed by 6560.59% in 2024.
  • Over the past 5 years, CollPlant Biotechnologies' Assets Average (Quarter) stood at $52.4 million in 2021, then decreased by 25.3% to $39.2 million in 2022, then tumbled by 56.38% to $17.1 million in 2023, then crashed by 45.17% to $9.4 million in 2024, then surged by 68.3% to $15.8 million in 2025.
  • Its last three reported values are $15.8 million in Q3 2025, $8.7 million for Q2 2025, and $9.4 million during Q1 2025.